Rare anthrax drug gets Real-World test in up to 10 patients
NCT ID NCT07478471
First seen Mar 26, 2026 · Last updated May 04, 2026 · Updated 8 times
Summary
This study will observe up to 10 people in the US who have lab-confirmed anthrax and are treated with the drug raxibacumab. Researchers want to see how well the drug works, including survival rates and side effects, by collecting data from medical records and blood samples. The goal is to learn more about treating anthrax in real-world situations, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS, BACTERIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.